Drawing for XYPIMCA

USPTO serial 79233971

XYPIMCA

Reviewed by CopyMark Law Group

Reg. 6060879Status 404
Filing date
Status date
Registration date
May 26, 2020
Examiner
PARKER, JUSTINE D
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with XYPIMCA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

NOVARTIS AGCH-4002Basel, 4002SWITZERLAND

Goods and services

ClassDescriptionStatusFirst use
005Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthmaSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 11, 2025DETHDEATH OF INTERNATIONAL REGISTRATION—
May 26, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 22, 2020TMBNTTAB RELEASE CASE TO TRADEMARKS—
Jun 14, 2019RINXUSPTO CORRECTION PROCESSED BY IB—
May 14, 2019CORRCORRECTION FROM IB ENTERED - NO REVIEW REQUIRED—
Mar 1, 2019GPNXNOTIFICATION PROCESSED BY IB—
Jan 28, 2019CRTPREG. CANCELLED - RESTORED TO PENDENCY—
Jan 25, 2019APETASSIGNED TO PETITION STAFF—
Jan 8, 2019RCIIREQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED—
Jan 2, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 2, 2019FIMPFINAL DISPOSITION PROCESSED—
Dec 28, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 28, 2018ES7RTEAS SECTION 7 REQUEST RECEIVED—
Dec 21, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 21, 2018ES7RTEAS SECTION 7 REQUEST RECEIVED—
Dec 20, 2018CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Dec 20, 2018GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB—
Dec 19, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 19, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 20, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 11, 2018ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Aug 30, 2018ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jul 31, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 11, 2018NPUBNOTICE OF PUBLICATION—
Jun 28, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 26, 2018DOCKASSIGNED TO EXAMINER—
Jun 16, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 12, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 11, 2018LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jun 7, 2018SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance